Furthermore, when two FGFR-2 mutants from the Apert and Crouzon syndromes were expressed in immature osteoblasts, both inhibited osteoblastic differentiation but also increased apoptosis [152] downregulating many Wnt targets and inducing SRY-box 2 (SOX-2), a transcription factor that maintains the undifferentiated state of cells [153] (Figure 4). The gene discussed is SOX2; the disease is Crouzon syndrome.